EDGAR Filing Documents for 0001213900-22-024626

Form POS AM - Post-Effective amendments for registration statement:

SEC Accession No. 0001213900-22-024626

Filing Date

2022-05-09

Accepted

2022-05-06 20:21:21

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	POST-EFFECTIVE REGISTRATION STATEMENT	posam2022_180lifesciences.htm	POS AM	7432196
2	OPINION OF DLA PIPER LLP (US)	posam2022ex5-1_180lifesci.htm	EX-5.1	22180
3	FORM OF 180 LIFE SCIENCES CORP. 2022 OMNIBUS INCENTIVE PLAN	posam2022ex10-34_180lifesci.htm	EX-10.34	178062
4	CONSENT OF MARCUM LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM	posam2022ex23-1_180lifesci.htm	EX-23.1	2223
5	FILING FEE TABLE	posam2022ex-fee_180lifesci.htm	EX-FILING FEES	49689
6	GRAPHIC	timage_001.jpg	GRAPHIC	555908
7	GRAPHIC	timage_002.jpg	GRAPHIC	265476
8	GRAPHIC	timage_003.jpg	GRAPHIC	123832
9	GRAPHIC	tflowchart_001.jpg	GRAPHIC	528402
10	GRAPHIC	ex5-1_001.jpg	GRAPHIC	11316
	Complete submission text file	0001213900-22-024626.txt		9731102

Mailing Address 830 MENLO AVENUE, SUITE 100 MENLO PARK CA 94025

Business Address 830 MENLO AVENUE, SUITE 100 MENLO PARK CA 94025 650-507-0669

180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)